Septarna (SEPN) | Financial Analysis & Statements
Septarna Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
24.1M
Operating Income
-16.0M
-66.44%
Net Income
-10.7M
-44.52%
EPS (Diluted)
$-0.24
Balance Sheet Metrics
Total Assets
596.2M
Total Liabilities
214.3M
Shareholders Equity
381.9M
Debt to Equity
0.56
Cash Flow Metrics
Operating Cash Flow
-17.6M
Free Cash Flow
-15.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Septarna Income Statement From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 46.0M | 1.1M | 151.0K | 0 |
| Cost of Goods Sold | - | - | - | - |
| Gross Profit | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | ||||
| Research & Development | 97.6M | 65.3M | 36.0M | 22.0M |
| Selling, General & Administrative | 29.2M | 16.6M | 9.7M | 5.9M |
| Other Operating Expenses | - | - | - | - |
| Total Operating Expenses | 126.7M | 81.9M | 45.7M | 28.0M |
| Operating Income | -80.8M | -80.8M | -45.6M | -28.0M |
| Operating Margin % | -175.8% | -7,518.4% | -30,165.6% | 0.0% |
| Non-Operating Items | ||||
| Interest Income | 19.5M | 8.6M | 2.8M | 291.0K |
| Interest Expense | - | - | - | - |
| Other Non-Operating Income | 12.4M | -90.0K | 47.6M | - |
| Pre-tax Income | -48.9M | -72.3M | 4.9M | -27.7M |
| Income Tax | 12.0K | -498.0K | 691.0K | 0 |
| Effective Tax Rate % | 0.0% | 0.0% | 14.2% | 0.0% |
| Net Income | -48.9M | -71.8M | 4.2M | -27.7M |
| Net Margin % | -106.4% | -6,678.9% | 2,768.2% | 0.0% |
| Key Metrics | ||||
| EBITDA | -91.7M | -79.4M | -92.3M | -27.4M |
| EPS (Basic) | - | $-7.26 | $0.03 | $-1.42 |
| EPS (Diluted) | - | $-7.26 | $0.03 | $-1.42 |
| Basic Shares Outstanding | - | 9891126 | 19495760 | 19495760 |
| Diluted Shares Outstanding | - | 9891126 | 19495760 | 19495760 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Septarna Balance Sheet From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & Equivalents | 120.7M | 238.2M | 88.5M | 30.6M |
| Short-term Investments | 270.4M | 112.7M | 0 | - |
| Accounts Receivable | 10.4M | 171.0K | 151.0K | 0 |
| Inventory | - | - | - | - |
| Other Current Assets | 1.2M | 200.0K | 92.0K | 204.0K |
| Total Current Assets | 411.0M | 356.8M | 112.7M | 31.9M |
| Non-Current Assets | ||||
| Property, Plant & Equipment | 27.8M | 29.3M | 17.5M | 3.7M |
| Goodwill | - | - | - | - |
| Intangible Assets | - | - | - | - |
| Long-term Investments | - | - | - | - |
| Other Non-Current Assets | 1.7M | 1.2M | 1.0M | 1.1M |
| Total Non-Current Assets | 185.2M | 99.7M | 18.2M | 4.2M |
| Total Assets | 596.2M | 456.6M | 130.9M | 36.1M |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | 10.3M | 3.2M | 2.6M | 3.1M |
| Short-term Debt | 2.2M | 1.9M | - | 710.0K |
| Current Portion of Long-term Debt | - | - | - | - |
| Other Current Liabilities | 148.0K | 78.0K | 85.0K | 50.0K |
| Total Current Liabilities | 86.9M | 12.8M | 6.9M | 5.5M |
| Non-Current Liabilities | ||||
| Long-term Debt | 21.4M | 23.6M | 12.6M | 0 |
| Deferred Tax Liabilities | - | - | - | - |
| Other Non-Current Liabilities | - | 33.0K | 546.0K | 83.0K |
| Total Non-Current Liabilities | 127.3M | 23.7M | 162.3M | 74.8M |
| Total Liabilities | 214.3M | 36.5M | 169.2M | 80.3M |
| Equity | ||||
| Common Stock | 45.0K | 44.0K | 3.0K | 3.0K |
| Retained Earnings | -167.3M | -118.4M | -46.6M | -50.8M |
| Treasury Stock | - | - | - | - |
| Other Equity | - | - | - | - |
| Total Shareholders Equity | 381.9M | 420.0M | -38.4M | -44.2M |
| Key Metrics | ||||
| Total Debt | 23.6M | 25.5M | 12.6M | 710.0K |
| Working Capital | 324.0M | 344.0M | 105.8M | 26.3M |
Balance Sheet Composition
Septarna Cash Flow Statement From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | -48.9M | -71.8M | 4.2M | -27.7M |
| Depreciation & Amortization | 1.6M | 1.4M | 848.0K | 577.0K |
| Stock-Based Compensation | 8.5M | 3.2M | 1.6M | 1.5M |
| Working Capital Changes | 162.2M | 981.0K | -1.4M | 1.4M |
| Operating Cash Flow | 125.6M | -65.3M | 6.6M | -23.7M |
| Investing Activities | ||||
| Capital Expenditures | -518.0K | -2.1M | -2.9M | -1.3M |
| Acquisitions | - | - | - | - |
| Investment Purchases | -451.0M | -213.4M | 0 | - |
| Investment Sales | 209.6M | 32.3M | 0 | - |
| Investing Cash Flow | -229.4M | -160.6M | 22.1M | -1.3M |
| Financing Activities | ||||
| Share Repurchases | -1.0K | -1.0K | -1.0K | - |
| Dividends Paid | - | - | - | - |
| Debt Issuance | - | - | - | - |
| Debt Repayment | - | - | - | - |
| Financing Cash Flow | -1.0K | 377.7M | 74.5M | 30.0M |
| Free Cash Flow | 109.7M | -69.6M | -41.6M | -24.6M |
| Net Change in Cash | -103.8M | 151.8M | 103.2M | 5.0M |
Cash Flow Trend
Septarna Key Financial Ratios
Valuation Ratios
Forward P/E
-12.68
Price to Book
2.89
Price to Sales
24.11
PEG Ratio
-12.68
Profitability Ratios
Profit Margin
-106.37%
Operating Margin
-66.44%
Return on Equity
-12.19%
Return on Assets
-9.59%
Financial Health
Current Ratio
4.73
Debt to Equity
6.19
Per Share Data
EPS (TTM)
$-1.10
Book Value per Share
$8.52
Revenue per Share
$1.04
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SEPN | 1.1B | - | 2.89 | -12.19% | -106.37% | 6.19 |
| Vertex | 109.4B | 28.40 | 5.92 | 22.54% | 32.94% | 10.91 |
| Regeneron | 81.0B | 18.00 | 2.45 | 14.86% | 31.41% | 9.51 |
| Capricor | 2.0B | -15.61 | 6.62 | -46.56% | 0.00% | 4.75 |
| Zymeworks | 2.0B | 3.79 | 7.32 | -26.72% | -76.56% | 6.80 |
| Taysha Gene | 1.8B | 2.53 | 7.39 | -68.45% | 0.00% | 28.41 |
Financial data is updated regularly. All figures are in the company's reporting currency.






